Drug & intervention
ramelteon
RxCUI 596205
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
8 shownThe Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyNCT02669082 · 2017-05-09
COMPLETEDTreating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With RamelteonNCT00907595 · 2009-05-01
WITHDRAWNRamelteon for Insomnia Comorbid With AsthmaNCT00869167 · 2008-03-01
TERMINATEDRamelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaNCT00595504 · 2008-01-01
COMPLETEDRamelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's DiseaseNCT00462254 · 2007-06-01
TERMINATEDTime to Remission of Depressive Symptoms With Combined SSRI and RamelteonNCT00642694 · 2007-05-01
TERMINATEDTreating Chronic Insomnia in Breast Cancer PatientsNCT00337272 · 2006-08-01
TERMINATEDEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseNCT00325728 · 2006-03-21
COMPLETEDConditions being studied
Research locations
BostonMassachusetts, United States3ChicagoIllinois, United States2AlbuquerqueNew Mexico, United States1AtlantaGeorgia, United States1AugustaGeorgia, United States1BillingsMontana, United States1BradentonFlorida, United States1BrooklynNew York, United States1BurlingtonVermont, United States1CantonOhio, United States1CincinnatiOhio, United States1ColumbusOhio, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.